Efficacy and Safety of JAK and TYK2 Inhibitors in Chronic Spontaneous Urticaria: A Systematic Review of 254 Patients
Journal of Cutaneous Medicine and Surgery · 17.11.2026
DOI: 10.1177/12034754261503932 ↗Kurz gefasst
Leserbrief in der Zeitschrift Journal of Cutaneous Medicine and Surgery, online erschienen am 17.11.2026. Verfasst von Elnaz Pourgholi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Razi Hospital, Tehran University of Medical Sciences, Iran. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology, Razi Hospital, Tehran University of Medical Sciences, Iran.
- Division of Dermatology, McGill University Health Centre, Montreal, QC, Canada.
- Division of Pediatric Allergy and Clinical Immunology, McGill University Health Centre, Montreal, QC, Canada.
- Department of Dermatology, University of Pittsburgh Medical Center, PA, USA.
ORCID-Profile: Seyed Mohammad Vahabi
Zitieren
APA
Pourgholi, E., Heidari, S., Esmaeili, F., Netchiporouk, E., Fein, M., Tung, J. K., & Vahabi, S. M. (2026). Efficacy and Safety of JAK and TYK2 Inhibitors in Chronic Spontaneous Urticaria: A Systematic Review of 254 Patients. Journal of Cutaneous Medicine and Surgery. https://doi.org/10.1177/12034754261503932
Vancouver
Pourgholi E, Heidari S, Esmaeili F, Netchiporouk E, Fein M, Tung JK, et al. Efficacy and Safety of JAK and TYK2 Inhibitors in Chronic Spontaneous Urticaria: A Systematic Review of 254 Patients. Journal of Cutaneous Medicine and Surgery. 2026. doi:10.1177/12034754261503932
BibTeX
@article{Pourgholi2026,
author = {Pourgholi, Elnaz and Heidari, Sama and Esmaeili, Farzad and Netchiporouk, Elena and Fein, Michael and Tung, Joe K and Vahabi, Seyed Mohammad},
title = {Efficacy and Safety of JAK and TYK2 Inhibitors in Chronic Spontaneous Urticaria: A Systematic Review of 254 Patients},
journal = {Journal of Cutaneous Medicine and Surgery},
year = {2026},
doi = {10.1177/12034754261503932}
}
EUVIMED